Actavis Laboratories UT, Inc. (DE) | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Actavis Laboratories UT, Inc. (DE)

Sort by

Viewing results 1‒25 of 114

The Art Market
Changing tastes hobble New York auction season
...It added that “having invested in the best state of the art equipment available”, Sotheby’s will “continue to analyse property in its own laboratories and is moving to an arrangement that is best suited...
November 23, 2023
HTSI15 travel destinations to book now
Untapping the inner beauty of Budapest
...I have been invited to Budapest by Stephen and Margaret de Heinrich de Omorovicza, founders of Hungarian skincare brand Omorovicza, whose products use the city’s thermal waters, together with a patented...
September 5, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
FT Magazine
Prediction markets can tell the future. Why is the US so afraid of them?
...In 1983, he founded Aristotle Inc, a technology consultancy that sold voter data to political campaigns....
November 10, 2023
InterviewNew York City
‘No big company is coming to the city’: biotech developer bemoans New York’s status
...But then when he left we had eight years literally of nothing,” Marcus said, faulting the administration of former mayor Bill de Blasio....
July 7, 2022
FT Alphaville
How to spend a million dollars, by Sam Bankman-Fried
...The research park’s own website says Alder is “a research laboratory focused on mycelium”....
December 19, 2022
European companies
French medtech companies make strides on heart devices
...But transplants are limited by the supply of donor organs, and existing LVAD technologies marketed by Abbott Laboratories and Medtronic often lead to complications....
January 6, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Consumer Electronics Show
Carmakers move from cars to building cities at CES
...Glen De Vos, chief technology officer at Aptiv, an automotive tech supplier, said carmakers have been stumbling in their efforts to become software-defined companies....
January 7, 2020
Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
October 31, 2017
US & Canadian companies
Sotheby’s files lawsuit over forgery of Italian Old Master
...Mr Martin is setting up laboratories in Sotheby’s New York and London offices....
January 18, 2017
US & Canadian companies
Carl Icahn buys ‘big’ stake in Allergan
...Actavis acquired Allergan, which makes the Botox cosmetic, last year and adopted its name after the deal closed....
May 31, 2016
World
Philippines’ Ayala comes full circle with push into healthcare
...Website | Subscribe. ©2016 Nikkei Inc. All rights reserved....
February 27, 2017
US healthcare reform
FT Health: Healthcare Trumped
...If Koch woke up from his grave, he would feel very familiar in the laboratory. It’s a failure of humanity — the bug is outsmarting us all. Why are we failing to achieve more?...
March 24, 2017
US & Canadian companies
Week in Review, November 12
...Mr de Combret is a former classmate of Alpha Condé, Guinea’s president....
November 11, 2016
FT AlphavilleAlexandra Scaggs
The US tax man might be coming for offshore corporate income
...Systems Inc. ($66bn, 19 per cent)Qualcomm Inc. ($29bn, 19 per cent)Corning Inc. ($11bn, 11 per cent)E.I. du Pont de Nemours & Co. ($16bn, 18 per cent) Berkshire Hathaway has $10bn of permanently reinvested...
October 17, 2016
Sport
Rio Olympics 2016: NBC bets big on blockbuster
...Comcast’s chief has called the X1’s Olympics platform a “laboratory” for the “future of television”....
August 7, 2016
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
News in-depthUS & Canadian companies
Biotech groups sink their teeth into the Big Apple
...Mr Bloomberg left office more than two years ago, replaced by Bill de Blasio, a Democrat with different priorities....
May 16, 2016
Law
Poison pill proves to be a deal-breaker
...The tie-up with Actavis also paved the way for further dealmaking....
December 8, 2015
US & Canadian companies
Pfizer’s Ian Read looks to count Allergan merger as his legacy
...But Allergan’s combination last year with Actavis — itself newly enlarged through a dizzying series of deals — created a company that fitted his two main criteria....
November 27, 2015
US & Canadian companies
Allergan signals appetite for new mega deal after $41bn disposal
...So could Mr Saunders be about to put on his laboratory coat and buy a company such as Biogen or AbbVie? “It’s possible....
July 27, 2015
US & Canadian companies
Shire Pharmaceuticals eyes the big league with Baxalta bid
...Others include Actavis, which bought Allergan, the maker of Botox, last year for $66bn and has since adopted the Allergan name....
August 4, 2015
US & Canadian companies
J&J and GSK join Medicxi’s European life sciences push
...Francesco De Rubertis, who led Index’s expansion in biotech, will make the switch to Medicxi along with several other partners....
February 2, 2016
News in-depthUS & Canadian companies
Allergan chief remains coy over Pfizer talks
...Most recently it bought Botox maker Allergan for $70bn and ditched the company’s previous name, Actavis....
November 5, 2015
US & Canadian companies
Large pill to swallow for Pfizer in Allergan deal
...Shortly after, Pfizer contacted Actavis, as Allergan was then known, about a potential deal, but the overture did not result in discussions....
October 29, 2015
US & Canadian companies
Hungry Actavis pauses to digest Allergan
...He says that of the world’s top 20 best-selling drugs, just “two or three were truly discovered in the laboratory”, with the rest being new takes on existing compounds....
January 21, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...resisted Teva’s advances, preferring instead to pursue its own $33bn hostile bid for Perrigo, a Dublin-based generic drugmaker, just two months after completing a $5.3bn acquisition of products from Abbott Laboratories...
April 26, 2015

Previous pagePage 1 of 5Next page